Venous Stents Market Updates

Global Venous Stents Market size was valued at USD 2.04 Billion in 2023 and is poised to grow from USD 2.13 Billion in 2024 to USD 3.06 Billion by 2032, growing at a CAGR of 4.62% in the forecast period (2025-2032).

The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation. 'Boston Scientific Corporation', 'Medtronic Plc', 'Becton, Dickinson and Company', 'Cook Medical', 'Gore Medical', 'Abbott Laboratories', 'Vesper Medical', 'Optimed Medizinische Instrumente GmbH', 'BIOTRONIK SE & Co. KG', 'Bentley InnoMed GmbH', 'Cordis Corporation', 'Plus medica GmbH & Co.', 'Philips Healthcare', 'Stryker Corporation'

Increase in chronic venous conditions like post-thrombotic syndrome and deep vein thrombosis globally is one of the key factors driving the growth of the venous stents market. Intervention therapy can be a requirement for the treatment of specific conditions to rejuvenate blood supply and alleviate the long-term impacts. Demand for venous stents is increasing in mature and emerging healthcare markets because of better diagnosis rates and greater awareness among aging populations, which is propelling the industry's steady growth.

Transition to Less Invasive Procedures: With shorter recovery periods, fewer risks of operation, and greater patient satisfaction, there is a global trend towards less invasive venous treatments. Venous stents play a key role in these methods, especially for venous diseases like iliofemoral vein obstruction. Demand for stents compatible with less invasive techniques is increasing as healthcare economics increasingly focus on outpatient and day surgery programs. This affects hospital buying habits and product design.

Why Does North America Dominate the Venous Stents Market?